NCT06094712View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 7, 2016

Primary Completion Date

April 27, 2016

Study Completion Date

April 27, 2016

Conditions
Healthy
Interventions
DRUG

CORT125134

CORT125134 150-mg capsule

Trial Locations (1)

49007

Jasper Clinic, Kalamazoo

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY